You are here

Atlantic Navigation, Seroja, Luzhou Bio-Chem, Ntegrator expect H1 losses

FOUR SGX-listed firms have guided for expected losses for the six months ended June: Atlantic Navigation, Ntegrator International, Seroja Investments and Luzhou Bio-Chem Technology.

Catalist-listed Atlantic Navigation expects to record a loss in both Q2 and H1, reversing profits from a year ago. This is mainly due to an impairment on certain vessels which are currently not on long-term charters.

Although the overall utilisation of the firm’s vessels is expected to be sustained at above 85 per cent for Q2, uncertainties from the adverse macro-economic environment and the Covid-19 pandemic may impact on utilisation and near-term earnings of these vessels, it said.

Nevertheless, Atlantic Navigation still expects to generate positive-adjusted Ebitda (earnings before interest, taxes, depreciation and amortisation) and net cash flows from operations in both Q2 and H1.

Communications-network specialist Ntegrator expects a loss in H1 due to a significant revenue decline in Q2. Its operations were hit by the Covid-19 circuit-breaker measures; the firm was unable to reduce fixed costs while income rapidly fell.

Your feedback is important to us

Tell us what you think. Email us at

Seroja expects its H1 losses to stem from from discontinued operations; Luzhou Bio-Chem did not specify the reasons for the anticipated loss.

Shares of Atlantic Navigation and Ntegrator closed flat at S$0.036 and S$0.009 respectively on Wednesday. Seroja closed at S$0.079, down 3.66 per cent, and Luzhou closed unchanged at S$0.029.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to